SOURCE: Xtalks

Xtalks Webinars

March 26, 2015 07:05 ET

Bioenhancement of Poorly Water Soluble Drugs: Challenges and Opportunities for Drug Development, New Webinar Hosted by Xtalks

TORONTO, ON--(Marketwired - March 26, 2015) - The educational and interactive webinar will discuss the factors affecting absorption and bio-availability, how the candidate properties from discovery affect the formulation development and how the formulation chemist can adopt particular bio-enhancement strategies to make compounds drugable. The live broadcast by Dr. Flavio Fabiani, from the Formulation and Material Science Division at Aptuit, takes place on Wednesday, April 22, 2015 at 11am EDT / 4pm BST (UK GMT +1).

The absorption and bioavailability of drugs can be limited by their solubility, dissolution rate, permeability or instability. The poor solubility of new chemical entities (NCEs) is one of the most frequent and greatest challenges to formulation scientists in the development of oral solid dosage forms. The historical pipelines of pharmaceutical companies are full of examples where NCEs are pharmacologically effective, but have not reached commercial launch due to insufficient bioavailability.

To learn more about this event visit: Bioenhancement of Poorly Water Soluble Drugs: Challenges and Opportunities for Drug Development

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit
For information about hosting a webinar visit

Image Available:

Contact Information